Unknown

Dataset Information

0

Effects of Nabilone on Sleep Outcomes in Patients with Parkinson's Disease: A Post-hoc Analysis of NMS-Nab Study.


ABSTRACT:

Background

The synthetic tetrahydrocannabinol analogue nabilone improved overall non-motor symptom (NMS) burden in Parkinson's disease (PD) patients in comparison to placebo.

Objectives

To characterize the effects of nabilone on different sleep outcomes in PD patients.

Methods

We performed a post-hoc analysis of the controlled, double-blind, enriched enrollment randomized withdrawal NMS-Nab study to assess the effects of nabilone on sleep outcomes in study participants who reported clinically-relevant sleep problems (MDS-UPDRS-1.7 ≥ 2 points).

Results

After open-label nabilone administration, 77.4% reported no relevant sleep problem. In the withdrawal phase of the trial, the MDS-UPDRS-1.7. and the NMS-Scale Domain 2 (i.e., Sleep/Fatigue) significantly worsened only in PD patients in the placebo group, which was mostly driven by a significant worsening of insomnia (question 5 of the NMS-Scale Domain 2).

Conclusions

This post-hoc analysis of the NMS-Nab trial suggests that nabilone has beneficial effects on sleep outcomes in PD patients experiencing sleep problems at baseline.The original trial was registered with ClinicalTrials.gov (NCT03769896, https://clinicaltrials.gov/ct2/show/NCT03769896) and EudraCT (2017-000192-86).

SUBMITTER: Peball M 

PROVIDER: S-EPMC9346252 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Effects of Nabilone on Sleep Outcomes in Patients with Parkinson's Disease: A Post-hoc Analysis of NMS-Nab Study.

Peball Marina M   Seppi Klaus K   Krismer Florian F   Knaus Hans-Günther HG   Spielberger Sabine S   Heim Beatrice B   Ellmerer Philipp P   Werkmann Mario M   Poewe Werner W   Djamshidian Atbin A  

Movement disorders clinical practice 20220531 6


<h4>Background</h4>The synthetic tetrahydrocannabinol analogue nabilone improved overall non-motor symptom (NMS) burden in Parkinson's disease (PD) patients in comparison to placebo.<h4>Objectives</h4>To characterize the effects of nabilone on different sleep outcomes in PD patients.<h4>Methods</h4>We performed a post-hoc analysis of the controlled, double-blind, enriched enrollment randomized withdrawal NMS-Nab study to assess the effects of nabilone on sleep outcomes in study participants who  ...[more]

Similar Datasets

| S-EPMC6647387 | biostudies-literature
| S-EPMC7540547 | biostudies-literature
| S-EPMC4923744 | biostudies-literature
| S-EPMC10146323 | biostudies-literature
| S-EPMC8789184 | biostudies-literature
| S-EPMC9397800 | biostudies-literature
| S-EPMC4320843 | biostudies-other
| S-EPMC9468087 | biostudies-literature
| S-EPMC7994695 | biostudies-literature
| S-EPMC7853195 | biostudies-literature